Retraction: Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin
Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin
- 1Department of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, China
- 2Department of Orthopedics, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
- 3Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
Citation: Li B, Zhao X, Zhang L and Cheng W (2021) Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin. Front. Oncol. 10:588533. doi: 10.3389/fonc.2020.588533
Received: 29 July 2020; Accepted: 24 December 2020;
Published: 09 February 2021; Retracted: 07 December 2023.
Edited by:
Jin-Ming Yang, University of Kentucky, United StatesReviewed by:
AHM Khurshid Alam, University of Rajshahi, BangladeshAgnieszka Zdzisława Robaszkiewicz, University of Łódź, Poland